Trial Profile
A randomized, double-blind, placebo-controlled multi-center study to evaluate the safety and efficacy of Fentanyl sublingual spray (Fentanyl SL spray) for the treatment of breakthrough cancer pain.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Registrational; Therapeutic Use
- Sponsors INSYS Therapeutics, Inc
- 19 May 2012 Results presented at the 31st Annual Scientific Meeting of the American Pain Society.
- 19 May 2010 Primary endpoint identified as pain relief as reported by ClinicalTrials.gov.
- 19 May 2010 Primary endpoint identified as pain relief as reported by ClinicalTrials.gov.